Registration

HOLLAND & KNIGHT LLP for TEVA PHARMACEUTICALS USA, INC.

Firm
Client
Income
—
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Drug pricing.

LobbyistCovered position, as disclosed
PAUL S. BOCK New Chief of Staff, Sen. Herb Kohl; Counsel, Senate Judiciary Committee
KATHRYN H LEHMAN New Special Assistant to Speaker of the House; Policy Director, House Majority Whip; Director of Coalition Outreach, Speaker of House; Chief of Staff, House Republican Conference
MICHAEL WERNER New —

Medicare/Medicaid MMM

Drug pricing.

LobbyistCovered position, as disclosed
PAUL S. BOCK New Chief of Staff, Sen. Herb Kohl; Counsel, Senate Judiciary Committee
KATHRYN H LEHMAN New Special Assistant to Speaker of the House; Policy Director, House Majority Whip; Director of Coalition Outreach, Speaker of House; Chief of Staff, House Republican Conference
MICHAEL WERNER New —

Pharmacy PHA

Drug pricing.

LobbyistCovered position, as disclosed
PAUL S. BOCK New Chief of Staff, Sen. Herb Kohl; Counsel, Senate Judiciary Committee
KATHRYN H LEHMAN New Special Assistant to Speaker of the House; Policy Director, House Majority Whip; Director of Coalition Outreach, Speaker of House; Chief of Staff, House Republican Conference
MICHAEL WERNER New —

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
TEVA PHARMACEUTICAL INSTUSTRIES LTD Israel Israel 100.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.